Granzyme and tumor(20)
1 Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes
2 HTLV-I infection of WE17/10 CD4+ cell line leads to progressive alteration of Ca2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformation
3 Granzyme H destroys the function of critical adenoviral proteins required for viral DNA replication and granzyme B inhibition
4 Healthy lifestyles are associated with higher levels of perforin, granulysin and granzymes A/B-expressing cells in peripheral blood lymphocytes ? ARTICLE
5 IFN2b stimulated release of IFN differentially regulates T cell and NK cell mediated tumor cell cytotoxicity ? ARTICLE
6 Granzyme B induction signalling pathway in acute myeloid leukemia cell lines stimulated by Tumor Necrosis Factor alpha and Fas Ligand ? ARTICLE
7 A Study of T Cell Tolerance to the Tumor-Associated Antigen MDM2: Cytokines Can Restore Antigen Responsiveness, but Not High Avidity T Cell Function.
8 Identification of cytotoxic T-lymphocyte epitope(s) and its agonist epitope(s) of a novel target for vaccine therapy (PAGE4).
9 Serial killing of tumor cells by human natural killer cells - enhancement by therapeutic antibodies.
10 Hepatocellular carcinoma cell supernatants increase expansion and function of CD4(+)CD25(+) regulatory T cells.
11 Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming.
12 Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes.
13 IL-12 controls cytotoxicity of a novel subset of self-antigen-specific human CD28+ cytolytic T cells.
14 Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection.
15 IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production.
16 Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destruction.
17 JNK2 negatively regulates CD8+ T cell effector function and anti-tumor immune response.
18 DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells.
19 Adoptive therapy of head and neck squamous cell carcinoma with antibody coated immune cells: a pilot clinical trial.
20 Granzyme B leakage-induced apoptosis is a crucial mechanism of cell death in nasal-type NK/T-cell lymphoma.